Brand profile · Biotechnology Research

EosGene Therapeutics

Sydney-based EosGene Therapeutics operates in Biotechnology Research. It is privately held, and its site is eosgene.com. It holds one address on record, all in Australia. Headcount on record is 1. Its work is tagged clinical trials. One Australian registration (ABN) is a confirmed match. It is listed alongside six similar brands, mostly in Biotechnology Research.

Profile live Privately Held Founded 2022 1 entity ABN 1 office country
Registry verified · ABR

Key facts

Counted staff
1
self-reported band not used
Founded
2022
4 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity
  • EOSGENE THERAPEUTICS PTY LTD

    ABN59660440826

    NSWHigh confidenceMatched on exact nameABR

Legal entities

EosGene Therapeutics: 1 registry entityEosGene Therapeutics is linked to 1 registry entity: EOSGENE THERAPEUTICS PTY LTD (ABN 59660440826, candidate).EosGene TherapeuticsEOSGENE THERAPEUTICSPTY LTDABN 59660440826Candidate · High confidence
Show as table · EosGene Therapeutics: 1 registry entity
EosGene Therapeutics: 1 registry entity
EOSGENE THERAPEUTICS PTY LTDABN 59660440826
Confirmed matches0 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

EosGene Therapeutics: Pioneering Gene Therapy for a Brighter Future

EosGene Tx is dedicated to address a significant healthcare challenge of diabetic retinopathy by harnessing the power of CRISPR-based gene therapy. With our ground-breaking liposome delivery technology, we're at the forefront of transforming treatment possibilities.

Our approach employs the revolutionary CRISPR editing tool to precisely target the disease-associated gene, paving the way for therapeutic breakthroughs. To ensure both effectiveness and safety of the therapy, we've developed an innovative liposome delivery technology that achieves the spatial-temporal release of CRISPR agents to the affected retinal cells.

Our objective is clear: to halt or even reverse the progression of diabetic retinopathy by correcting genetic mutations and dysfunctions at their source.

Guided by world-class scientists and business leaders, our team brings a wealth of experience and expertise in the dynamic realm of biotechnology.

Specialties

All 7 specialties
  • Nanoparticles
  • Liposomes
  • Gene Therapy
  • Clinical Trials
  • Safer
  • more efficient and affordable treatments
  • Genome Editing

Locations

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary AU. Codes: AU.1 countryprimary AUAU
Show as table · Offices in 1 country
Offices in 1 country
Countries1
Primary countryAU

All codes: AU

Addresses

  • AUSydneyPrimary

Grid intelligence Members

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

1 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Names are withheld until a consented source exists.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under EosGene Therapeutics?

One New South Wales entity on the ABR: EOSGENE THERAPEUTICS PTY LTD (ABN 59 660 440 826), high confidence.

How many people work at EosGene Therapeutics?

1 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.

Where does EosGene Therapeutics have offices?

One address on record, Australia only. Primary: Sydney.

Has EosGene Therapeutics raised funding?

None linked to this brand.

What does EosGene Therapeutics list as its specialties?

Seven tags on the brand's own list, among them clinical trials.

Which companies are listed alongside EosGene Therapeutics?

4 profiles list EosGene Therapeutics as a peer — 56th percentile in Biotechnology Research. It lists ten peers of its own. SMART CRC and Preview Health list it back.